Vascular Solutions Reports Second Quarter Results

Go back to Vascular Solutions Reports Second Quarter Results

Piper Jaffray Raises Price Target on Vascular Solutions (VASC) to $49 Following 2Q Beat

July 26, 2016 8:07 AM EDT

Piper Jaffray reiterated an Overweight rating on Vascular Solutions (NASDAQ: VASC), and raised the price target to $49.00 (from $45.00), following the company's 2Q earnings report. VASC reported revenue of $41.2M, slightly ahead of the consensus of $41.1M. Adjusted EPS was also ahead of consensus coming in at $0.33 compared to $0.30. Management was very upbeat regarding the... More

Vascular Solutions (VASC) Tops Q2 EPS by 3c, Updates FY Guidance

July 25, 2016 4:10 PM EDT

Vascular Solutions (NASDAQ: VASC) reported Q2 EPS of $0.33, $0.03 better than the analyst estimate of $0.30. Revenue for the quarter came in at $41.2 million versus the consensus estimate of $41.4 million.

GUIDANCE:

Vascular Solutions sees FY2016 EPS of $1.22-$1.26, versus the consensus of... More